C2N Diagnostics Receives $20M Program-Related Investment from GHR Foundation to Bring Alzheimer’s Blood Test to the Clinic
PRIVATEMay 14, 2020
Amount Raised
$20 Million
Round Type
Venture
India
Description
C2N Diagnostics announced today that it has received a $20 million Program-Related Investment from GHR Foundation, an independent global philanthropy. The funds will position C2N’s Alzheimer’s blood test for entry into the clinic. The investment provides resources to build out C2N’s clinical laboratory testing facility in St. Louis, Missouri and to establish a premium quality, patient testing service
Who to call, and when
A new round usually means this company is about to hire and buy. The teams that reach out first get the meeting.
An alert the day this company raises, hires an executive or expands, scored against what you sell
The decision-makers to reach, with verified emails
Who you already know there, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call and when. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Location
India
About
AccelFoods is an early-stage venture fund investing in consumer products.
We partner with entrepreneurs to bring innovative, high-quality food and
beverage products to the forefront of the industry and create the next
generation of enduring brands. With nearly $40m under management, we are
hands-on partners that work tactically with our founders to scale their
businesses quickly and smartly. We connect the dots within the broader food
& beverage ecosystem to provide unique access, share distinct expertise,
and build solid infrastructure.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment this company raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
India